AMH (anti-Müllerian hormone) is primarily a marker of ovarian reserve, not a tool for blood sugar management. Some research explores links between AMH and insulin resistance, but the evidence is weak and insufficient for clinical recommendations. The provided knowledge context contains no data on AMH or blood sugar. Therefore, a conservative stance is warranted: AMH should not be used to manage blood sugar. For glucose control, established markers like fasting glucose, HbA1c, and insulin, along with lifestyle interventions (diet, exercise), are the standard. An AMH test is not indicated for this purpose. Evidence grade: unclear. Caveat: No direct evidence in context; marketing may overstate associations.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-605011a788459f2bdb18b16b